Cargando…

Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China

Background: Within China's hierarchical medical system, many patients seek medical care in different hospitals independently without integrated management. As a result, multi-hospital visiting is associated with fragmented service utilization and increased incidence of polypharmacy behaviors, e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jia, Feng, Zhanchun, Dong, Zhongxin, Li, Wanping, Chen, Chaoyi, Gu, Zhichun, Wei, Anhua, Feng, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815858/ https://www.ncbi.nlm.nih.gov/pubmed/35126137 http://dx.doi.org/10.3389/fphar.2021.802097

Ejemplares similares

What Factors Hindered the Access to Essential Anticancer Medicine in Public Hospitals for the Local Population in Hubei Province, China
por: Chen, Chaoyi, et al.
Publicado: (2021)

Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China
por: Zong, Qiao, et al.
Publicado: (2023)

Predictors of Polypharmacy Among Elderly Patients in China: The Role of Decision Involvement, Depression, and Taking Chinese Medicine Behavior
por: Chen, Chaoyi, et al.
Publicado: (2021)

Safety of Using Traditional Chinese Medicine Injections in Primary Medical Institutions: Based on the Spontaneous Reporting System 2016–2020 in Henan Province, China
por: Yan, Ziqi, et al.
Publicado: (2022)

The impact of key monitoring policy on the usage of policy-related drugs in Hubei Province, China
por: Wen, Xiaotong, et al.
Publicado: (2023)

Analysis of the behavior change mechanism of township hospital health workers in Hubei Province, China: A cross-sectional study
por: He, Zhifei, et al.
Publicado: (2018)

Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database
por: Jiao, Zhiming, et al.
Publicado: (2022)

Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

The severity of adverse drug reactions and their influencing factors based on the ADR monitoring center of Henan Province
por: Yan, Ziqi, et al.
Publicado: (2021)

Author Correction: The severity of adverse drug reactions and their influencing factors based on the ADR monitoring center of Henan Province
por: Yan, Ziqi, et al.
Publicado: (2022)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
por: Sciarra, Tommaso, et al.
Publicado: (2019)

What Contributes to the Regularity of Patients with Hypertension or Diabetes Seeking Health Services? A Pilot Follow-Up, Observational Study in Two Sites in Hubei Province, China
por: Feng, Da, et al.
Publicado: (2016)

Community-Level Pharmaceutical Interventions to Reduce the Risks of Polypharmacy in the Elderly: Overview of Systematic Reviews and Economic Evaluations
por: Soler, Orenzio, et al.
Publicado: (2019)

Research on Maternal Service Area and Referral System in Hubei Province, China
por: Bai, Lingyao, et al.
Publicado: (2022)

Polypharmacy Cut-Off for Gait and Cognitive Impairments
por: Langeard, Antoine, et al.
Publicado: (2016)

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019
por: Cho, Ho Jin, et al.
Publicado: (2022)

Gravitational scaling analysis on spatial diffusion of COVID-19 in Hubei Province, China
por: Chen, Yanguang, et al.
Publicado: (2021)

Pathogenic Leptospira Infections in Hubei Province, Central China
por: Xu, Jiale, et al.
Publicado: (2022)

MERS-related CoVs in hedgehogs from Hubei Province, China
por: Li, Dan, et al.
Publicado: (2021)

Sharply Reduced but Still Heavy Self-Harm Burdens in Hubei Province, China, 1990–2015
por: Pan, Jingju, et al.
Publicado: (2018)

Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
por: Kurczewska-Michalak, M., et al.
Publicado: (2021)

Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
por: Li, Zhuoxian, et al.
Publicado: (2021)

Evaluation of Health Care System Reform in Hubei Province, China
por: Sang, Shuping, et al.
Publicado: (2014)

The availability, price and affordability of essential antibacterials in Hubei province, China
por: Wu, Guangjie, et al.
Publicado: (2018)

Characteristics of Dissolved Organic Matter in Sediments of Typical Lakes in Southeastern Hubei Province, China
por: Wu, Chao, et al.
Publicado: (2022)

Safety Profile of Antipsychotic Drugs: Analysis Based on a Provincial Spontaneous Reporting Systems Database
por: Guo, Kangyuan, et al.
Publicado: (2022)

Use of public data to describe COVID-19 contact tracing in Hubei Province and non-Hubei provinces in China between 20 January and 29 February 2020
por: Dirlikov, Emilio, et al.
Publicado: (2019)

Characteristics of Diagnosed and Death Cases of Pneumoconiosis in Hubei Province, China, 1949–2019
por: Yao, Yuxin, et al.
Publicado: (2022)

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
por: Zhang, Naiqi, et al.
Publicado: (2020)

Onychomadesis and potential association with HFMD outbreak in a kindergarten in Hubei province, China, 2017
por: Li, Dan, et al.
Publicado: (2019)

Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021
por: Tian, Fangyuan, et al.
Publicado: (2022)

Does having a usual primary care provider reduce patient self-referrals in rural China’s rural multi-tiered medical system? A retrospective study in Qianjiang District, China
por: Feng, Da, et al.
Publicado: (2017)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation
por: Takamoto, Kojiro, et al.
Publicado: (2021)

Geriatrician-led multidisciplinary team management improving polypharmacy among older inpatients in China
por: Song, Yi, et al.
Publicado: (2023)

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
por: Cebrino, Jesús, et al.
Publicado: (2023)

Spatiotemporal distribution of schistosomiasis transmission risk in Jiangling County, Hubei Province, P.R. China
por: Feng, Jiaxin, et al.
Publicado: (2023)

Feasibility of containing shigellosis in Hubei Province, China: a modelling study
por: Rui, Jia, et al.
Publicado: (2020)

Genetic and Clinical Characteristics of Patients With Hereditary Spherocytosis in Hubei Province of China
por: Wang, Xiong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ehblslir7srsli801krk2nvsbk